Status:
COMPLETED
Presence of Circulating Tumor DNA in Colorectal Cancer
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
18-85 years
Brief Summary
Cancer is a DNA disease characterized by the presence of genetics alterations in cancer cells. The recent studies underline that these recurring alterations must be considered as a good molecular mar...
Detailed Description
Two major issues appear in improving the prognosis of cancer patients, the first is early detection and the second is the risk of recurrence or the early diagnosis of recurrence in order to propose th...
Eligibility Criteria
Inclusion
- patients aged Superior to 18 and inferior to 85
- Colon or rectal cancer stage II and III should be surgically treated
- informed consent signed
Exclusion
- patients suffered from synchronous metastasis disease in initial cancer diagnosis
- patients with 2 synchronous colorectal cancers
- receiving chemotherapy or radiotherapy, before operation
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT01198743
Start Date
November 1 2005
End Date
May 1 2017
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HEGP
Paris, France, 75015